GSK plc (GLAXF)
OTCMKTS
· Delayed Price · Currency is USD
18.22
0.00 (0.00%)
Feb 21, 2025, 3:00 PM EST
GSK plc Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Revenue | 31,376 | 30,328 | 29,324 | 24,696 | 24,354 | Upgrade
|
Revenue Growth (YoY) | 3.46% | 3.42% | 18.74% | 1.40% | -27.85% | Upgrade
|
Cost of Revenue | 8,845 | 8,388 | 9,407 | 8,033 | 7,321 | Upgrade
|
Gross Profit | 22,531 | 21,940 | 19,917 | 16,663 | 17,033 | Upgrade
|
Selling, General & Admin | 10,853 | 9,156 | 8,179 | 6,784 | 7,041 | Upgrade
|
Research & Development | 6,078 | 5,823 | 5,153 | 4,627 | 4,397 | Upgrade
|
Other Operating Expenses | -969 | -1,442 | -737 | -382 | -455 | Upgrade
|
Operating Expenses | 15,962 | 13,537 | 12,595 | 11,029 | 10,983 | Upgrade
|
Operating Income | 6,569 | 8,403 | 7,322 | 5,634 | 6,050 | Upgrade
|
Interest Expense | -669 | -710 | -819 | -762 | -844 | Upgrade
|
Interest & Investment Income | 122 | 108 | 62 | 13 | 26 | Upgrade
|
Earnings From Equity Investments | -3 | -5 | -2 | 33 | 33 | Upgrade
|
Other Non Operating Income (Expenses) | - | -75 | -46 | -6 | -24 | Upgrade
|
EBT Excluding Unusual Items | 6,019 | 7,721 | 6,517 | 4,912 | 5,241 | Upgrade
|
Merger & Restructuring Charges | -353 | -382 | -321 | -424 | -1,178 | Upgrade
|
Gain (Loss) on Sale of Investments | 6 | -121 | 256 | 1 | -242 | Upgrade
|
Gain (Loss) on Sale of Assets | - | 61 | 215 | 552 | 2,857 | Upgrade
|
Asset Writedown | -314 | -398 | -296 | -347 | -200 | Upgrade
|
Legal Settlements | - | - | 922 | - | - | Upgrade
|
Other Unusual Items | -1,881 | -817 | -1,665 | -1,095 | -1,308 | Upgrade
|
Pretax Income | 3,477 | 6,064 | 5,628 | 3,599 | 5,170 | Upgrade
|
Income Tax Expense | 526 | 756 | 707 | 83 | 67 | Upgrade
|
Earnings From Continuing Operations | 2,951 | 5,308 | 4,921 | 3,516 | 5,103 | Upgrade
|
Earnings From Discontinued Operations | - | - | 10,495 | 1,069 | 876 | Upgrade
|
Net Income to Company | 2,951 | 5,308 | 15,416 | 4,585 | 5,979 | Upgrade
|
Minority Interest in Earnings | -376 | -380 | -460 | -200 | -230 | Upgrade
|
Net Income | 2,575 | 4,928 | 14,956 | 4,385 | 5,749 | Upgrade
|
Net Income to Common | 2,575 | 4,928 | 14,956 | 4,385 | 5,749 | Upgrade
|
Net Income Growth | -47.75% | -67.05% | 241.07% | -23.73% | 23.77% | Upgrade
|
Shares Outstanding (Basic) | 4,077 | 4,052 | 4,026 | 4,003 | 3,981 | Upgrade
|
Shares Outstanding (Diluted) | 4,142 | 4,111 | 4,084 | 4,052 | 4,030 | Upgrade
|
Shares Change (YoY) | 0.75% | 0.66% | 0.79% | 0.55% | 0.43% | Upgrade
|
EPS (Basic) | 0.63 | 1.22 | 3.71 | 1.10 | 1.44 | Upgrade
|
EPS (Diluted) | 0.62 | 1.20 | 3.66 | 1.08 | 1.43 | Upgrade
|
EPS Growth | -48.12% | -67.26% | 238.48% | -24.16% | 23.23% | Upgrade
|
Free Cash Flow | 5,155 | 5,454 | 6,260 | 7,002 | 7,452 | Upgrade
|
Free Cash Flow Per Share | 1.24 | 1.33 | 1.53 | 1.73 | 1.85 | Upgrade
|
Dividend Per Share | 0.610 | 0.580 | 0.613 | 1.000 | 1.000 | Upgrade
|
Dividend Growth | 5.17% | -5.31% | -38.75% | 0% | 0% | Upgrade
|
Gross Margin | 71.81% | 72.34% | 67.92% | 67.47% | 69.94% | Upgrade
|
Operating Margin | 20.94% | 27.71% | 24.97% | 22.81% | 24.84% | Upgrade
|
Profit Margin | 8.21% | 16.25% | 51.00% | 17.76% | 23.61% | Upgrade
|
Free Cash Flow Margin | 16.43% | 17.98% | 21.35% | 28.35% | 30.60% | Upgrade
|
EBITDA | 9,240 | 10,304 | 9,089 | 7,756 | 8,100 | Upgrade
|
EBITDA Margin | 29.45% | 33.98% | 31.00% | 31.41% | 33.26% | Upgrade
|
D&A For EBITDA | 2,671 | 1,901 | 1,767 | 2,122 | 2,050 | Upgrade
|
EBIT | 6,569 | 8,403 | 7,322 | 5,634 | 6,050 | Upgrade
|
EBIT Margin | 20.94% | 27.71% | 24.97% | 22.81% | 24.84% | Upgrade
|
Effective Tax Rate | 15.13% | 12.47% | 12.56% | 2.31% | 1.30% | Upgrade
|
Advertising Expenses | - | 835 | 735 | 433 | 361 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.